Maria cristina Mingari

Maria cristina Mingari's AcademicInfluence.com Rankings

Biology

#9811

World Rank

#13059

Historical Rank

Immunology

#594

World Rank

#614

Historical Rank

biology Degrees

Download Badge

Biology

Maria cristina Mingari's Degrees

Bachelors Biology University of California, Berkeley
PhD Immunology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Maria cristina Mingari Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Maria cristina Mingari's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. (2001) (1872)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. (2006) (1011)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. (2008) (986)
Receptors for HLA class-I molecules in human natural killer cells. (1996) (900)
What is a natural killer cell? (2002) (468)
Mesenchymal stem cells inhibit natural killer – cell proliferation , cytotoxicity , and cytokine production : role of indoleamine 2 , 3-dioxygenase and prostaglandin E 2 (2008) (449)
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. (2000) (401)
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison (1980) (397)
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. (1999) (394)
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes (1997) (382)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. (2009) (380)
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. (1976) (372)
Expression of a receptor for IgM by human T cells in vitro (1975) (371)
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells (1984) (364)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). (2005) (363)
Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells (2008) (343)
Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity (1983) (340)
Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG (1978) (313)
Effector and regulatory events during natural killer–dendritic cell interactions (2006) (313)
Effect of tumor cells and tumor microenvironment on NK‐cell function (2014) (302)
Surface NK receptors and their ligands on tumor cells. (2006) (289)
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. (1996) (283)
Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. (1998) (279)
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. (2012) (264)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity (2009) (252)
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. (1998) (249)
Human natural killer cells: their origin, receptors and function (2002) (248)
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. (1995) (243)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications (2019) (228)
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. (2011) (226)
Human natural killer cells: origin, clonality, specificity, and receptors. (1994) (226)
Increased natural cytotoxicity receptor expression and relevant IL‐10 production in NK cells from chronically infected viremic HCV patients (2007) (220)
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression (2010) (215)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation (2019) (193)
Human NK-cell receptors. (2000) (192)
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. (2011) (191)
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells (2011) (190)
NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures (2015) (190)
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes (2003) (190)
Interleukin‐15‐induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2‐A as the only HLA class I‐specific inhibitory receptor (1997) (182)
Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor (1988) (181)
Transforming growth factor‐β‐induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes (1999) (176)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph (2014) (172)
T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function (1994) (169)
Different checkpoints in human NK-cell activation. (2004) (166)
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function (2013) (155)
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. (1999) (152)
Origin, phenotype and function of human natural killer cells in pregnancy. (2011) (144)
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. (2009) (139)
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. (2005) (136)
Loss of Fc receptors for IgG from human T lymphocytes exposed to IgG immune complexes (1978) (134)
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production (2013) (133)
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV‐1‐infected patients (2004) (130)
Identification of diverse innate lymphoid cells in human decidua (2014) (129)
Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations (1983) (128)
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. (2005) (128)
Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells. (2014) (124)
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. (2006) (124)
Surface markers of cloned human T cells with various cytolytic activities (1981) (123)
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications (2014) (122)
PD‐L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections (2018) (120)
Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes. (1980) (120)
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. (1997) (115)
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. (2008) (111)
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells (2013) (108)
Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen. (1979) (107)
Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response (2012) (101)
NK-CTLs, a novel HLA-E-restricted T-cell subset. (2003) (100)
Melanoma cells become resistant to NK‐cell‐mediated killing when exposed to NK‐cell numbers compatible with NK‐cell infiltration in the tumor (2012) (99)
Unique Eomes+ NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy (2016) (98)
The analysis of the natural killer‐like activity of human cytolytic T lymphocytes revealed HLA‐E as a novel target for TCR α/β‐mediated recognition (2001) (98)
Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells (2002) (98)
Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells* (2013) (95)
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors (1991) (94)
Human T Cell Subpopulations in Normal and Pathologic Conditions (1979) (94)
Imbalances of T cell subpopulations in patients with atopic diseases and effect of specific immunotherapy. (1979) (93)
The Emerging Role of HLA-E-Restricted CD8+ T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors (2010) (91)
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. (2010) (90)
Functional analysis of cloned germinal center CD4+ cells with natural killer cell-related features. Divergence from typical T helper cells. (1986) (90)
Human natural killer cell function and receptors. (2001) (86)
T.6. Mesenchymal Stem Cells Inhibit Natural Killer Cell Proliferation, Cytotoxicity and Cytokine Production: Role of Indoleamine 2,3-Dioxygenase and Prostaglandin E2 (2009) (86)
Human NK cells and their receptors. (2002) (85)
Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function (1984) (85)
Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation. (1982) (84)
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability (2017) (82)
NK cells and ILCs in tumor immunotherapy. (2020) (82)
Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration (2018) (80)
Identification of effector‐memory CMV‐specific T lymphocytes that kill CMV‐infected target cells in an HLA‐E‐restricted fashion (2005) (79)
CD3+4−8−WT31− (T cell receptor γ+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2‐responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis (1987) (79)
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. (2007) (79)
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. (1997) (79)
The corticosteroid‐induced inhibitory effect on NK cell function reflects down‐regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity (2004) (74)
Markers and function of human NK cells in normal and pathological conditions (2017) (72)
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. (2009) (72)
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation (2015) (72)
Immune response in the conjunctival epithelium of patients with dry eye. (2010) (72)
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua (2016) (68)
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? (2016) (67)
NKG2D engagement of colorectal cancer‐specific T cells strengthens TCR‐mediated antigen stimulation and elicits TCR independent anti‐tumor activity (2003) (67)
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production (2010) (65)
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. (2008) (65)
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition (2016) (64)
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors (2014) (64)
Assignment of human natural killer (NK)‐like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK‐sensitive target cells via distinct recognition structures (1984) (63)
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. (2000) (63)
Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. (2000) (61)
Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation (2004) (61)
Generation of CFU-C/suppressor T cells in vitro: an experimental model for immune-mediated marrow failure. (1981) (59)
Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. (1995) (58)
Stromal Cells from Human Decidua Exert a Strong Inhibitory Effect on NK Cell Function and Dendritic Cell Differentiation (2014) (57)
Molecular definition of group 1 innate lymphoid cells in the mouse uterus (2018) (57)
Development of human natural killer cells and other innate lymphoid cells. (2014) (57)
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A‐mediated regulation of proliferation and cytolytic activity (1996) (57)
Lymphokine production by T-cell clones after human bone marrow transplantation. (1989) (56)
Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. (2012) (55)
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor (2019) (55)
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs. (2009) (53)
Identification of a novel cell binding site of periostin involved in tumour growth. (2011) (52)
Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15 (2008) (51)
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes (2001) (51)
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA‐E during active tuberculosis and express type 2 cytokines (2015) (50)
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture (1981) (50)
Human T cell receptor for IgM: specificity for the pentameric Fc fragment (1976) (49)
Human natural killer cell function and their interactions with dendritic cells. (2003) (49)
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. (2004) (48)
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines. (2018) (48)
Molecular and Cellular Analysis of Human T Lymphocytes Expressing γδ T‐Cell Receptor (1991) (48)
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells (2009) (47)
Fc-receptors for IgG and IgM immunoglobulins on human T lymphocytes: mode of re-expression after proteolysis or interaction with immune complexes. (1978) (47)
Glucocorticoids and the cytokines IL-12, IL-15 and IL-18 present in the tumor microenvironment induce PD-1 expression on human Natural Killer cells. (2020) (47)
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells. (2009) (46)
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism (2014) (44)
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua (2018) (44)
Human NK cells, their receptors and function (2021) (44)
In vivo generation of decidual natural killer cells from resident hematopoietic progenitors (2014) (43)
A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma. (2013) (43)
Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. (1993) (43)
Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua (2019) (43)
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? (2018) (42)
Human T cells expressing the gamma/delta T-cell receptor (TcR-1): C gamma 1- and C gamma 2-encoded forms of the receptor correlate with distinctive morphology, cytoskeletal organization, and growth characteristics. (1989) (42)
In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis (1990) (42)
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages (2014) (41)
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer (2020) (41)
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin (1984) (40)
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans (2019) (40)
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short‐term IL‐2 activation (2013) (40)
Natural killer cells in human pregnancy. (2013) (39)
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua (2019) (38)
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors. (2005) (38)
Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells. (1982) (38)
Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones (1984) (37)
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. (2001) (37)
Ultrastructural characteristics of human T cell clones with various cytolytic activities (1983) (37)
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer (2020) (37)
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias (2016) (37)
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation (2016) (37)
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. (2010) (36)
Human NK receptors: From the molecules to the therapy of high risk leukemias (2011) (36)
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. (2008) (36)
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board. (2019) (36)
Human NK cells: From surface receptors to clinical applications. (2016) (35)
Human innate lymphoid cells. (2016) (33)
Membrane Transfer from Tumor Cells Overcomes Deficient Phagocytic Ability of Plasmacytoid Dendritic Cells for the Acquisition and Presentation of Tumor Antigens (2014) (32)
Human peripheral blood lymphocytes bearing T cell receptor gamma/delta. Expression of CD8 differentiation antigen correlates with the expression of the 55-kD, C gamma 2-encoded gamma chain (1988) (31)
Human melanoma cells express a functional interleukin‐2 receptor (1993) (31)
Exploiting Human NK Cells in Tumor Therapy (2020) (30)
Origin and functions of human natural killer cells (1994) (30)
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes NK Cell Activation1 (2005) (30)
Cellular and molecular basis of natural killer and natural killer-like activity. (2003) (30)
Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma. (2008) (30)
Combined Genotypic and Phenotypic Killer Cell Ig-Like Receptor Analyses Reveal KIR2DL3 Alleles Displaying Unexpected Monoclonal Antibody Reactivity: Identification of the Amino Acid Residues Critical for Staining (2010) (30)
Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. (2001) (29)
B cell growth factor activity of immunoaffinity‐purified and recombinant human interleukin 2 (1985) (29)
Receptors for IgM are expressed on acute lymphoblastic leukemic cells having T-cell characteristics. (1977) (28)
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. (2000) (28)
Human lymphocyte surface markers. (1982) (28)
Human T‐Lymphocyte Subpopulations: Alterations in Systemic Lupus Erythematosus (1979) (27)
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment (2015) (27)
NKp44 expression, phylogenesis and function in non-human primate NK cells. (2009) (27)
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c‐Myc protein (2008) (27)
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 (2018) (26)
ANALYSIS OF NATURAL KILLER CELLS ISOLATED FROM HUMAN DECIDUA : EVIDENCE THAT 2 B 4 ( CD 244 ) FUNCTIONS AS AN INHIBITORY RECEPTOR AND BLOCKS NK CELL FUNCTION Running title : dNK cells and 2 B 4 function (2006) (26)
T cell nature of some lymphokine‐activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells (1986) (25)
The molecular basis of Natural Killer (NK) cell recognition and function (1996) (25)
MSC and innate immune cell interactions: A lesson from human decidua. (2015) (25)
How melanoma cells inactivate NK cells (2012) (25)
Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5. (2009) (24)
Lysozyme-Induced Inhibition of the Lymphocyte Response to Mitogenic Lectins 1 (1989) (23)
Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors. (2005) (22)
Cytolytic function of clonable T cells after human bone marrow transplantation. (1990) (22)
CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV‐1 infection (2010) (21)
Differential NKp30 Inducibility in Chimpanzee NK Cells and Conserved NK Cell Phenotype and Function in Long-Term HIV-1-Infected Animals1 (2007) (21)
Ontogeny, specific functions and receptors of human natural killer cells. (1994) (21)
IL‐1β inhibits ILC3 while favoring NK‐cell maturation of umbilical cord blood CD34+ precursors (2015) (21)
Phenotypic and functional analysis of human CD3 + and CD3− clones with “lymphokine‐activated killer” (LAK) activity. Frequent occurrence of CD3 + LAK clones which produce interleukin‐2 (1987) (21)
Role of the calpain-calpastatin system in the density-dependent growth arrest. (2008) (20)
Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report. (2002) (20)
Role of Ia antigens in the human autologous mixed lymphocyte reaction (1982) (19)
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients. (2003) (19)
Role of NK cells in immunotherapy and virotherapy of solid tumors. (2015) (19)
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. (1996) (19)
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients (2017) (19)
Anticlonotypic monoclonal antibodies induce proliferation of clonotype- positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells (1985) (19)
Stimulatory receptors in NK and T cells. (1998) (18)
Quantitative Evaluation of Ocular Surface Inflammation in Patients with Different Grade of Conjunctivochalasis (2010) (18)
A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors (2017) (18)
Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals (2007) (18)
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts (2015) (18)
Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens (2017) (17)
Human T lymphocytes expressing gamma/delta T cell antigen receptor. (1989) (17)
Recent advances in the phenotypic and functional analysis of human T lymphocytes. (1984) (17)
Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. (2010) (17)
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes. (1998) (17)
Immunobiology of human NK cells. (2001) (17)
Characterization of the calpain/calpastatin system in human hemopoietic cell lines. (2006) (17)
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. (1996) (15)
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. (2014) (15)
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. (2009) (15)
Melanoma immunoediting by NK cells (2012) (15)
IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors (2015) (14)
Surface receptors that regulate the NK cell function: beyond the NK cell scope. (2002) (14)
HO‐1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition (2020) (14)
Surface molecules involved in CD3‐negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells (1989) (14)
Phenotypic and functional characteristics of tumor‐associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin‐2 (ril‐2) (1989) (14)
Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma (2020) (14)
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid (2017) (14)
NK cells from malignant pleural effusions are potent antitumor effectors (2013) (13)
Human natural killer cells in pregnancy (2012) (13)
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity (2022) (13)
Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection. (2000) (13)
Imbalance of T-cell subpopulations and defective pokeweed mitogen-induced B-cell differentiation after bone marrow transplantation in man. (1981) (13)
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function (2016) (13)
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic (2003) (13)
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules. (2020) (13)
Glycine-rich cell wall proteins act as specific antigen targets in autoimmune and food allergic disorders. (2000) (12)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications (2019) (12)
Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia (2020) (11)
Human CD3+4-8-WT31- T lymphocyte populations expressing the putative T cell receptor gamma-gene product. A limiting dilution and clonal analysis. (1987) (11)
An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human Decidua (2020) (11)
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 (2020) (11)
Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance? (2020) (10)
Characterization of Human Afferent Lymph Dendritic Cells from Seroma Fluids (2013) (10)
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy (2020) (10)
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (2022) (10)
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function (2018) (10)
Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E. (2007) (9)
Development of human NK cells from the immature cell precursors. (1995) (9)
Natural killer cell receptors regulate responses of HLA-E–restricted T cells (2021) (9)
Different types of effector cells involved in non-mhc-restricted cytolytic activity. (1988) (8)
L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model (2019) (8)
Inhibitory receptors for HLA class I molecules on cytolytic T lymphocytes (1997) (8)
Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells (2020) (8)
Surface markers of human T lymphocytes (1982) (7)
Human T cells expressing the y/6 T-cell receptor (TcR-1): Ci,-and CY2-encoded forms of the receptor correlate with distinctive morphology, cytoskeletal organization, and growth characteristics (7)
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells (2021) (7)
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab (2019) (7)
Phenotypic and functional heterogeneity of human T lymphocytes producing B-cell growth factor(s): a clonal analysis. (1985) (6)
Receptors for immunoglobulins and activation markers on human T lymphocytes. (1982) (6)
Expression of a wide T cell receptor Vβ repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors (1994) (6)
Natural killer cells in pregnancy: How do they avoid attacking fetal tissues? (1999) (6)
Natural killer cells: From surface receptors to the cure of high‐risk leukemia (Ceppellini Lecture) (2019) (6)
Bone Marrow Transplantation for Severe Aplastic Anemia (1979) (5)
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production (2013) (5)
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. (2013) (5)
Expression of HLA class l‐specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host? (1997) (4)
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. (2001) (4)
Interleukin-2-Induced proliferation of CD4-CD8- human thymocytes.In vitro expression of CD3 and CD8 antigens and cytolytic activity (1988) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Partial inefficiency of T cell receptors γ/δ composed of a heavy (55-kD) γ chain to mediate cell activation upon binding to specific monoclonal antibodies (1989) (4)
ANALYSIS OF SURFACE PROPERTIES, FINE STRUCTURE AND ORGAN DISTRIBUTION OF TWO DISTINCT T-CELL SUBPOPULATIONS: Tμ AND Tγ (1977) (4)
Characterization of KIR + NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C (2022) (4)
Anti-Leukemia Activity of Alloreactive NK Cells in Haploidentical HSCT in Pediatric Patients: Re-Defining the Role of Activating and Inhibitory KIR (2008) (3)
TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better (2020) (3)
T cell subpopulations after allogeneic bone marrow transplantation. (1980) (3)
Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias. (2003) (3)
Phenotypic and functional heterogeneity of human T cell clones producing γ-interferon (1985) (3)
Interleukin-2 production in response to phytohemagglutinin is not necessarily dependent upon the T3-mediated pathway of T-cell activation. (1986) (3)
Does Lissamine Green Staining of the Ocular Surface Correlate with Inflammation in Dry Eye Patients (2012) (3)
Immunoregulatory subpopulations of human T lymphocytes. (1979) (3)
Regulatory Interactions of Human T Cells (1980) (2)
Immunoregulatory T Cell Subpopulations in Man (1980) (2)
Melanoma Cells Inhibit NK Cell Functions—Response (2012) (2)
Human RORgtCD34 Cells Are Lineage-Specified Progenitors of Group 3 RORgt Innate Lymphoid Cells (2019) (2)
Nectin-2 (CD112) evidence for the involvement of the Poliovirus receptor (CD155) and mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: - Analysis of the receptor-ligand interactions in the natural killer (2013) (2)
PROLIFERATIVE RESPONSIVENESS OF TWO DISTINCT HUMAN T-CELL SUBPOPULATIONS TO CON A, PHA AND ALLOANTIGENS (1977) (2)
CYTOLYTIC T LYMPHOCYTES IN MIXED LYMPHOCYTE CULTURE (1981) (2)
The Effect of Tapered Small Dose Steroidal Treatment on Symptoms, Clinical Signs, and Ocular Surface Inflammation in Patients with Dry Eye Syndrome (2011) (2)
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability (2018) (2)
Thymic origin of some natural killer cells: clonal proliferation of human CD3−16+ cells from CD3−4−8− thymocyte precursors requires the presence of H9 leukemic cells (1992) (2)
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise? (2022) (2)
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy (2022) (2)
Glycoproteic nature of surface molecules of effector cells with lymphokine‐activated killer (LAK) activity. Evidence that T11, T8 or T3 molecules are not involved in tumor‐cell lysis by LAK effector T cells (1987) (1)
Analysis of CD3-associated molecules in CD4− 8− human T cell clones lacking the typical α/β T cell receptor (1987) (1)
Therapeutics , Targets , and Chemical Biology CXCL 12 / CXCR 4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer (2011) (1)
CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection (European Journal of Immunology (2010) 40, 5 DOI: 10.1002/eji. 200940062) (2010) (1)
Review Article The Emerging Role of HLA-E-Restricted CD8 + TLymphocytesin the Adaptive Immune Response to Pathogens and Tumors (2010) (1)
inhibit IL-2-induced NK-cell proliferation activated NK cells are capable of killing MSCs, whereas MSCs can Mesenchymal stem cell-natural killer cell interactions: evidence that (2012) (1)
Phenotypic and functional heterogeneity of human T cell clones producing gamma-interferon. (1985) (1)
Perturbations of NK cell regulatory functions in respiratory allergic diseases (2007) (1)
HLA class-I-specific inhibitory receptor in human T lymphocytes: interference with T-cell functions. (1997) (1)
Group 3 NCR+ Innate Lymphoid Cells accumulate in human lung cancer (2016) (1)
Correction to IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34+ precursors [Eur. J. Immunol, 45, 7, (2015)] DOI 10.1002/eji.201445326 (2015) (1)
CHAPTER 14 – CLINICAL RELEVANCE OF SUBPOPULATIONS OF HUMAN T LYMPHOCYTES (1979) (1)
CHAPTER 25 – SUBPOPULATIONS OF HUMAN T LYMPHOCYTES: FUNCTIONAL CHARACTERISTICS (1979) (1)
Expression of periostin and syndecan-1 in endometriosis (2014) (1)
HIV-1-Infected Animals Cell Phenotype and Function in Long-Term Chimpanzee NK Cells and Conserved NK Differential NKp 30 Inducibility in (2007) (1)
Partial inefficiency of T cell receptors gamma/delta composed of a heavy (55-kD) gamma chain to mediate cell activation upon binding to specific monoclonal antibodies. (1989) (1)
Erratum: Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells (International Immunology (2008) vol. 20 (565-575)) (2008) (1)
Su.103. Phenotipic and Functional Characterization of Human Decidual Natural Killer Cells (2008) (1)
P3.02c-072 Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer: Topic: IT Biomarkers (2017) (1)
Critical for Staining Identification of the Amino Acid Residues Monoclonal Antibody Reactivity : KIR 2 DL 3 Alleles Displaying Unexpected Cell Ig-Like Receptor Analyses Reveal Combined Genotypic and Phenotypic Killer (2010) (1)
The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity (2022) (1)
Relationship between expression of Fcγ receptors or la antigens and cytolytic activities of alloactivated human T cells (1983) (1)
Bone marrow transplantation for severe aplastic anemia. A report of 9 cases. (1979) (0)
HLA-G-specific receptors in human NK or T lymphocytes (1997) (0)
Analysis of CD8 T-cells recognising Mycobacterium tuberculosis antigen presented by HLA-E molecule (2014) (0)
Surface markers of resting and activated human T cells. Functional implications and experimental limits (2005) (0)
Fc receptors on human T lymphocytes: loss of Fc mu and expression of Fc gamma receptors by T cells stimulated in mixed lymphocyte reaction. (1981) (0)
immune-mediated marrow failure Generation of CFU-C/suppressor T cells in vitro: an experimental model for (2011) (0)
Regulation of HLA antigen expression in phagocytes with mycobacteria (1997) (0)
Human T lymphocyte markers and function: A major research goal of the group working at the Cancer Institute in Genova (Laboratory of Immunopathology) (1988) (0)
ILC3s: Rhythmic Keepers of Gut Integrity at Mealtime. (2020) (0)
Recent Advances in Human Natural Killer Cells. (1992) (0)
HIV-1-infected animals phenotype and function in long-term chimpanzee NK cells and conserved NK cell Differential NKp 30 inducibility in (2007) (0)
Recent Progress in Human Natural Killer Cell Ontogeny (1994) (0)
Surface Phenotype of Helper and Suppressor Human T Cell Clones (1983) (0)
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells. (2023) (0)
Generation of CFUC suppressor T cells in vitro: VII. T derived colony inhibitory activity (Td/CIA) has no suppressor effect on in vitro immunoglobulin production. (1983) (0)
Brief Definitive Report HUMAN PERIPHERAL BLOOD LYMPHOCYTES BEARING T CELL RECEPTOR y/S Expression of CD8 Differentiation Antigen Correlates with the Expression of the 55-kD, Cy2-encoded y Chain (2003) (0)
Hunan T cell subpopulations in normal and pathologic conditions. (1979) (0)
MHC CLASS I-SPECIFIC INHIBITORY RECEPTORS EXPRESSED BY NK AND T LYMPHOCYTES (2000) (0)
Human lymphocytes expressing a TCR gamma/delta. (1990) (0)
Dendritic Cells from Seroma Fluids Characterization of Human Afferent Lymph (2013) (0)
Regulation of HLA antigen expression in phagocytes treated with mycobacteria (1997) (0)
HO-1 down-regulation increases the efficacy of BRAFV600E inhibition-based therapy in primary melanoma cells (2016) (0)
Novel isoforms of peroxiredoxin 5 encode a unique melanoma antigen and can provide dual-binding peptides for classical and nonclassical HLA molecules (2006) (0)
Analysis of CD3-associated molecules in CD4- 8- human T cell clones lacking the typical alpha/beta T cell receptor. (1987) (0)
Title: Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and re-definition of inhibitory KIR specificity. Running title: Anti-leukemia alloreactive NK cells in haplo-HSCT AUTHORS: (2008) (0)
Author response for "Human NK cells, their receptors and function" (2021) (0)
LymphSecondary Lymphoid Organs via Afferent Neoplastic Solid Tissues and Recirculate to NK Cells Are Abundant in Both Healthy and Noncytotoxic Human low Perforin bright CD56 (2014) (0)
Difficulties and new strategies in the identification of functional T cell populations in humans. (1983) (0)
44-OR: Recognition of HLA-E by natural killer cells is impacted by variation in cytomegalovirus UL40 sequences in haemopoietic stem cell transplantation (2009) (0)
Both the precursors and the effectors of human lymphokine-activated killer (LAK) cells may belong to T lymphocytes (1986) (0)
Surface molecules involved in antigen independent cell activation (1988) (0)
Corrigendum to ‘Understanding human NK cell differentiation: Clues for improving the haploidentical hematopoietic stem cell transplantation’ [Immunol. Lett. 155 (2013) (1–2) 2–5] (2014) (0)
Contents, Vol. 99, 1992 (1992) (0)
Phenotypic and functional characterization of human T lymphocytes expressing a gamma/delta T cell antigen receptor. (1989) (0)
Contents Vol. 164, 2014 (2014) (0)
Relationship between expression of Fc gamma receptors or Ia antigens and cytolytic activities of alloactivated human T cells. (1983) (0)
Receptors involved in human NK cell activation in the process of natural cytotoxicity (2001) (0)
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions (2010) (0)
In vitro immuno globulin production is not inhibited by t derived colony inhibitory activity (1983) (0)
Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies. (1982) (0)
Recent progresses in the phenotypic and functional characterization of human cytolytic T lymphocytes (1984) (0)
Natural killer recognition of primary melanoma cells treated with BRAFV600E inhibitor is favored by heme oxygenase 1 down-regulation (2018) (0)
Cell Activation Subsets of Human Dendritic Cells Tunes NK Distinctive Lack of CD48 Expression in (2005) (0)
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua (2019) (0)
CTL-P and the precursors of effector T cells exhibiting a natural killer (NK)-like activity. * Recipient of a short-term fellowship from the European Molecular Biology Organization. Supported in part by grants 81.01421.96 and 82.00332.96 PFCCN from CNR (2003) (0)
LORENZO MORETTA , ANt ) (2003) (0)
Evaluation of possible correlation between skin ultrasound and circulating fibrocytes in limited cutaneous systemic sclerosis patients (2019) (0)
Dendritic cells: function (PP-024) (2010) (0)
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer (2020) (0)
Dendritic cells: function (PP-024) (2010) (0)
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis (1998) (0)
Molecular definition of group 1 innate lymphoid cells in the mouse uterus (2018) (0)
NK cells and NK receptors (WS-007) Chairpersons: Hisashi Arase, Noriko Toyama-Sorimachi (2010) (0)
Physiological and Pathological Aspects of Human NK Cells (2012) (0)
Is there a role for tapered topical dose steroidal treatment for dry eye disease? A randomized, pilot study (2021) (0)
IL-15-induced expression of the CD94/NKG2a HLA-class I-specific inhibitory receptors in NK cells derived from early thymic precursors (1997) (0)
Clonal Analysis of Human T Lymphocytes Inducing B Cell Growth (1986) (0)
OR.69. Hla-E-Restricted Cytolytic T Lymphocytes: Their Role in Cytomegalovirus Infection and Transplantation (2006) (0)
Brief DeBnitive Report (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Maria cristina Mingari?

Maria cristina Mingari is affiliated with the following schools:

University of Genoa

Maria cristina Mingari's Academic­Influence.com Rankings